← Leaderboards
Marvin Epolian Langston
Kaiser Foundation Research Institute
$1,509,245
Attributed
$2,402,939
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $831.3K · FY2021–25$1M$750K$500K$250K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,402,939 · 2
By mechanism
R01$1,787,388 · 1
K01$615,551 · 1
Top collaborators
- Siobhan Sutcliffe3 shared
Most similar at Kaiser Foundation Research Institute
Same institution · by research overlap
- Stephen Sidney$24,122,844
- Stephen K. Van Den Eeden$13,042,835
- Jennifer S Lee$2,192,988
- Sheila A Weinmann$3,662,976
Others in their field
Other Emerging Leaders on “Prostate”
- Leonard Freedman · Leidos Biomedical Research, Inc.$63,277,106
- Greg Yothers · University Of Chicago$35,003,821
- Lynn Briscoe · Leidos Biomedical Research, Inc.$30,044,343
- Leonard Freedmand · Leidos Biomedical Research, Inc.$11,639,100
- John Freymann · Leidos Biomedical Research, Inc.$8,749,308
- Himisha Beltran · Dana-Farber Cancer Inst$7,515,798
Research focus
ProstateDiagnosisMalignant Neoplasm Of ProstateCostMemberElectronic Health RecordFutureInvestigationOlder MenRacePreventCohortBlack MenCessation Of LifeBaseBenignAcuteAssociated SymptomAsian AmericansAdrenergic AntagonistsCoupledCaringAdrenergic Alpha-AntagonistsComparative Effectiveness
Grant awards (7)
Tailored prostate cancer screening: addressing USPSTF priority research gaps in a racially-diverse study population$567,769
R01 · FY2025 · CA · contact PI
Tailored prostate cancer screening: addressing USPSTF priority research gaps in a racially-diverse study population$539,382
R01 · FY2024 · CA · contact PI
Long-term effectiveness of BPH/LUTS pharmacological therapies and using machine learning based predictive analytics to tailor treatment$151,068
K01 · FY2024 · DK · contact PI
Tailored prostate cancer screening: addressing USPSTF priority research gaps in a racially-diverse study population$680,237
R01 · FY2023 · CA · contact PI
Long-term effectiveness of BPH/LUTS pharmacological therapies and using machine learning based predictive analytics to tailor treatment$151,068
K01 · FY2023 · DK · contact PI
Long-term effectiveness of BPH/LUTS pharmacological therapies and using machine learning based predictive analytics to tailor treatment$153,068
K01 · FY2022 · DK · contact PI
Long-term effectiveness of BPH/LUTS pharmacological therapies and using machine learning based predictive analytics to tailor treatment.$160,347
K01 · FY2021 · DK · contact PI